Agranulocytosis associated with sulphasalazine therapy.
D000107:Acetylation; D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced*; D000906:Antibodies / Q000032:analysis; D005260:Female; D006801:Humans; D007962:Leukocytes / Q000276:immunology; D012460:Sulfasalazine / Q000009:adverse effects*; D013997:Time Factors
D000906:Antibodies; D012460:Sulfasalazine